Related Experiment Video
Updated: Dec 26, 2025
04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11.0K
[Bilateral lung irradiation as adjuvant therapy in osteogenic sarcoma ]
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|July 8, 1982
Summary
Bilateral lung irradiation may help prevent osteosarcoma pulmonary metastases. This study reviews evidence supporting its use, tolerable doses, and optimal methods, awaiting controlled trial confirmation.
Area of Science:
- Oncology
- Radiotherapy
- Medical Physics
Background:
- Pulmonary metastases are a significant challenge in osteosarcoma treatment.
- The role of bilateral lung irradiation and chemotherapy in preventing these metastases remains controversial.
Purpose of the Study:
- To present theoretical and experimental evidence supporting bilateral lung irradiation for osteosarcoma.
- To analyze clinical data and describe optimal irradiation modalities.
- To emphasize the need for controlled trials to confirm efficacy.
Main Methods:
- Review of theoretical and experimental data on lung irradiation.
- Analysis of clinical experience with bilateral lung irradiation in osteosarcoma.
- Description of optimal radiation therapy techniques and dosage.
Main Results:
- Evidence suggests that bilateral lung irradiation can be considered for preventing pulmonary metastases.
- Tolerable radiation doses for normal lung tissue are discussed.
- Optimal irradiation modalities are outlined based on current data.
Conclusions:
- Bilateral lung irradiation, alongside chemotherapy, warrants further investigation for osteosarcoma metastasis prevention.
- Controlled clinical trials, such as the ongoing EORTC study, are crucial for definitive confirmation.
- Optimized radiation techniques may enhance the therapeutic ratio.
